FDA Calendar

May 3-6, San Antonio

AMERICAN PAIN SOCIETY'S 25th ANNUAL SCIENTIFIC MEETING

Includes presentation from DOV Pharmaceutical Inc. on Bicifadine as analgesic in animal models of neuropathic pain and data from phase 3 trial results and presentation from XenoPort, Inc. on phase 2a clinical trial of XP13512 for post-herpetic neuralgia

May 5, Rockville, Md.

ONCOLOGIC DRUGS ADVISORY COMMITTEE MEETING (FDA)

Committee to discuss New Drug Application 21-824 for Tibotec Therapeutics' Zarnestra (tipifarnib) film-coated tablets for the treatment of elderly patients with newly diagnosed poor-risk acute myeloid leukemia

May 7-11, San Juan, Puerto Rico

19th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

Includes presentations from FermaVir Pharmaceuticals Inc. on research and development on compounds for shingles as well as others on antiviral drug and antiviral chemotherapy research

May 10-12, Bethesda, Md.

2nd ANNUAL PHARMADISCOVERY CONFERENCE

Includes presentation from Rigel Pharmaceuticals Inc. on the development of aurora kinase inhibitor R763 for cancer

May 13, Gaithersburg, Md.

ANESTHESIOLOGY AND RESPIRATORY THERAPY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)

Committee to hear presentation on FDA's critical path initiative and a presentation from the Office of Surveillance and Biometics in the Center for Devices and Radiological Health

May 14-17, Scottsdale, Ariz.

WOUND HEALING SOCIETY 16th ANNUAL MEETING & EXHIBITION

Includes presentation from Helix BioMedix Inc. on hexapeptides for bacterial and fungal infections

May 15-20, Toronto

ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOCIATION

Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert, a urine-based diagnostic aid, and its successful clinical studies

May 16-19, Paris

EuroPCR INTERVENTIONAL CARDIOLOGY MEETING

Includes presentation from NMT Medical Inc. on results for its BioSTAR study on bioabsorbable collagen matrix technology for biological closure of heart defects

May 16-20, New York

AMERICAN SOCIETY OF HYPERTENSION ANNUAL SCIENTIFIC MEETING AND EXPOSITION

Includes presentation from Medicure Inc. on phase 2 Matched study with MC-4232 for cardiovascular and metabolic risk factors

May 17, Gaithersburg, Md.

OBSTETRICS AND GYNECOLOGY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)

Includes presentation from the Office of Surveillance and Biometrics in the Center for Devices and Radiological Health on its responsibility for the review of postmarket study design and discussion, recommendations and vote on a premarket approval application for a spectroscopy-based cervical imaging system for use as an adjunct to colposcopy to enhance the identification of biopsy sites

May 17, Gaithersburg, Md.

PERIPHERAL AND CENTRAL NERVOUS SYSTEM DRUGS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on Novartis Pharmaceuticals Corp.'s supplemental New Drug Application 20823, SE1-016, Exelon capsules for mild to moderate dementia associated with Parkinson's disease

May 17-18, Baltimore

INDUSTRY EXCHANGE WORKSHOP ON FOOD AND DRUG ADMINISTRATION CLINICAL TRIAL REQUIREMENTS

Public workshop in cooperation with the Society of Clinical Research Associates on FDA clinical trial statutory and regulatory requirements

May 18-19, Silver Spring, Md.

DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on risk assessment program marketed drugs, including review and analysis of spontaneous reports of adverse events

May 19, Gaithersburg, Md.

ANTIVIRAL DRUGS ADVISORY COMMITTEE MEETINGS (FDA)

Includes discussion on New Drug Application 21-814, proposed trade name Aptivus (Tipranavir) capsules for Boehringer Ingelheim Pharmaceuticals Inc. for human immunodeficiency virus

May 20, Rockville, Md.

CELLULAR, TISSUE AND GENE THERAPIES ADVISORY COMMITTEE MEETING (FDA)

Includes update on individual research programs in the division of therapeutic proteins, center for drug evaluation and research

May 20-25, Los Angeles

ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOCIATION

Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert test's successful clinical studies

May 20-25, Los Angeles

DIGESTIVE DISEASE WEEK CONFERENCE

Includes presentation from Callisto Pharmaceuticals Inc. on Guanilib for gastrointestinal inflammation; presentation from Idenix Pharmaceuticals Inc. on Valopicitabine, an nucleoside polymerase inhibitor for hepatitis C and presentation from Cytogen Corp. on Prostascint, a diagnostic imaging agent for newly diagnosed patients with biopsy-proven prostate cancer; presentation on antiviral activity of ViroPharma Inc. and Wyeth's HCV-796

May 21-25, Orlando, Fla.

106th AMERICAN SOCIETY FOR MICROBIOLOGY ANNUAL GENERAL MEETING

Includes presentation from Helix BioMedix Inc. on hexapeptides for bacterial and fungal infections

May 31-June 3, Scottsdale, Ariz.

20th CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS' ANNUAL MEETING

Includes presentation from PharmaFrontiers Corp. on study of patients treated with monovalent T cell therapy

June 1-5, San Francisco

2006 ANNUAL MEETING OF THE FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES

Includes presentation from PharmaFrontiers Corp. on proprietary T-cell vaccination technology for autoimmune disease multiple sclerosis

June 2, Atlanta

ONCOLOGIC DRUGS ADVISORY COMMITTEE MEETING (FDA)

Committee to provide advice and recommendations to the agency on FDA's regulatory issues, to discuss Bristol-Myers Squibb Co.'s New Drug Application for Sprycel (dasatinib) tablets for the treatment of adults with chronic, accelerated or blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy

June 2-6, Atlanta

2006 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING

Includes presentation from Oncolytics Biotech Inc. on Reolysin clinical trial data, Bioenvision Inc. on Evoltra for adult acute myeloid leukemia; presentation from Cytogen Corp. on Quadramet for multiple myeloma and Cell Genesys Inc. on trial of GM-CSF-gene transduced allogeneic prostate cancer cellular immunotherapy with human anti-CTLA-4 antibody for hormone-refractory prostate cancer and K562/GM-CSF vaccination for tumor burden related to chronic myelogenous leukemia; presentations from ChondroGene Ltd. on use of blood biomarkers to detect colorectal cancer and prostate cancer; presentation from Antisoma plc on phase 2 study of AS1404 for lung cancer and ovarian cancer as well as the phase 1 study of R1550 for breast cancer and presentation from Genitope Corp. on phase 2 clinical trial of MyVax for follicular Non-Hodgkine's Lymphoma

June 21-24, Amsterdam

EUROPEAN LEAGUE AGAINST RHEUMATISM 2006 ANNUAL CONGRESS

Includes presentation from Savient Pharmaceuticals Inc. on phase 2 trial results for Puricase

June 21-23, Toulon, France

14TH INTERNATIONAL SYMPOSIUM ON HIV AND EMERGING INFECTIOUS DISEASES

Includes presentation from Adventrx Pharmaceuticals Inc. on antiviral activity of Thiovir

July 12-15, Washington

13th WORLD CONFERENCE ON TOBACCO OR HEALTH

Includes presentation from Nymox Pharmaceutical Corp. on results for saliva NicAlert test for tobacco exposure

July 23-27, Chicago

AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY ANNUAL MEETING

Includes presentation for PreMD Inc. on abstract for microwell-based format of LungAlert for lung cancer

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.